Who owns INSMED INC?
- CUSIP Number: 457669ab5
Tip: Access positions for across all investors
Analyze quarterly positions in Insmed with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Insmed stock
Who bought or sold INSMED INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 69M | $79M | 0% | Dec 2023 |
|
| Franklin Resources | 60M | $69M | 0% | Dec 2023 |
|
| Balyasny Asset Management | 32M | $37M | 8% | Dec 2023 |
|
| Capstone Investment Advisors | 30M | $34M | 11% | Dec 2023 |
|
| Citadel Advisors | 28M | $32M | -4% | Dec 2023 |
|
| Calamos Advisors | 26M | $29M | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 25M | $29M | 913% | Dec 2023 |
|
| Whitebox Advisors | 24M | $28M | 31% | Dec 2023 |
|
| Readystate Asset Management | 19M | $22M | 27% | Dec 2023 |
|
| Lord, Abbett & Co | 19M | $21M | -23% | Dec 2023 |
|
| Segantii Capital Management | 15M | $17M | 100% | Dec 2023 |
|
| LMR Partners | 15M | $17M | -25% | Dec 2023 |
|
| Point72 Asset Management | 13M | $15M | 100% | Dec 2023 |
|
| Context Capital Management | 10M | $12B | 84661% | Dec 2023 |
|
| Lazard Asset Management | 10M | $12M | -20% | Dec 2023 |
|
| SSI Investment Management | 7.6M | $8.7M | -18% | Dec 2023 |
|
| CSS | 5.9M | $6.8M | 16% | Dec 2023 |
|
| Absolute Investment Advisers | 5.0M | $5.3B | -44% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 5.0M | $5.7M | 0% | Dec 2023 |
|
| Man Group | 2.7M | $3.1M | 0% | Dec 2023 |
|
| Royal Bank of Canada | 2.4M | $2.8M | 9% | Dec 2023 |
|
| Credit Suisse | 2.2M | $1.9M | 0% | Dec 2023 |
|
| Amundi | 2.0M | $2.2M | -4% | Dec 2023 |
|
| Shenkman Capital Management | 1.7M | $2.0B | 100% | Dec 2023 |
|
| Palisade Capital Management | 1.7M | $1.9M | 0% | Dec 2023 |
|
| RWC Asset Management | 1.6M | $1.8M | -20% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 1.1M | $1.2M | 1% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 870k | $994k | -46% | Dec 2023 |
|
| Jane Street | 800k | $913k | 100% | Dec 2023 |
|
| Groupama Asset Managment | 600k | $688k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 400k | $459k | 0% | Dec 2023 |
|
| Fox Hill Wealth Management | 136k | $146k | 4% | Mar 2024 |
|
| First Hawaiian Bank | 133k | $142k | 0% | Mar 2024 |
|
| Calamos Wealth Management | 110k | $126k | -21% | Dec 2023 |
|
| Argent Trust | 25k | $29k | 0% | Dec 2023 |
|
| Stonegate Investment Group | 13k | $14k | -54% | Mar 2024 |
|
| SG Americas Securities | 8.9k | $1.0M | -84% | Dec 2023 |
|
| Bank of America Corporation | 6.0k | $6.9k | -100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 4.0k | $4.6k | -100% | Dec 2023 |
|
| Wells Fargo & Company | 2.0k | $2.3k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 1.0k | $1.1k | 0% | Dec 2023 |
|
| Barclays | 1.0k | $1.0k | -100% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 400.00 | $459k | 0% | Dec 2023 |
|
Who sold out of Insmed?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| CNH Partners | Sep 2023 | 6.7M | $6.7M |
| Aequim Alternative Investments | Sep 2023 | 5.0M | $5.0M |
| Monashee Investment Management | Sep 2023 | 3.0M | $3.0M |